12 Results

People

  1. Drilon
    Drilon
  2. Hechtman
    Hechtman
  3. Ladanyi
    Ladanyi
  4. Hyman
    Hyman
  5. Benayed
    Benayed
  6. Frosina
    Frosina
  7. Jungbluth
    Jungbluth
  8. Rosen
    Rosen
  9. Zehir
    Zehir
  10. Mullaney
    Mullaney

Groups

  1. Department of Medicine (12)
  2. GSK Faculty (12)
  3. Human Oncology and Pathogenesis Program (12)
  4. Solid Tumor Oncology Division (12)
  5. Thoracic Oncology (12)
  6. Tow Center for Developmental Oncology (TCDO) (12)
  7. Early Drug Development Service (10)
  8. Sloan Kettering Institute Postdocs (5)
  9. Gynecologic Medicine Service (3)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  1. "Department of Medicine"
  2. "Journal article"
  3. "Alexander Drilon"
  4. "Jaclyn Hechtman"
  5. "Tow Center for Developmental Oncology (TCDO) "
Formats
  1. Journal Article (12)
Groups
  1. Department of Medicine (12)
  2. GSK Faculty (12)
  3. Human Oncology and Pathogenesis Program (12)
  4. Solid Tumor Oncology Division (12)
  5. Thoracic Oncology (12)
  6. Tow Center for Developmental Oncology (TCDO) (12)

More Groups

People
  1. Alexander Drilon (12)
  2. Jaclyn Hechtman (12)
  3. Marc Ladanyi (12)
  4. David Hyman (8)
  5. Ryma Benayed (8)
  6. Ahmet Zehir (6)

More People

Years
  1. 2024 (1)
  2. 2021 (2)
  3. 2020 (2)
  4. 2019 (2)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Clinical Cancer Research (3)
  2. American Journal of Surgical Pathology (2)
  3. Annals of Oncology (2)
  4. Cancer Research (1)
  5. JCO Precision Oncology (1)
  6. Journal of Thoracic Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Lippincott Williams & Wilkins (2)
  3. Oxford University Press (2)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Inc. (1)
  6. Massachusetts Medical Society (1)

More Publishers

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • A performance comparison of commonly used assays to detect RET fusions
    Journal Article

    Yang, S. R.; Aypar, U.; Rosen, E. Y.; Mata, D. A.; Benayed, R.; Mullaney, K.; Jayakumaran, G.; Zhang, Y.; Frosina, D.; Drilon, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Overcoming MET-dependent resistance to selective RET inhibition in patients with RET fusion-positive lung cancer by combining selpercatinib with crizotinib
    Journal Article

    Rosen, E. Y.; Johnson, M. L.; Clifford, S. E.; Somwar, R.; Kherani, J. F.; Son, J.; Bertram, A. A.; Davare, M. A.; Gladstone, E.; Ivanova, E. V.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients
    Journal Article

    Ross, D. S.; Liu, B.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • NTRK fusion detection across multiple assays and 33,997 cases: Diagnostic implications and pitfalls
    Journal Article

    Solomon, J. P.; Linkov, I.; Rosado, A.; Mullaney, K.; Rosen, E. Y.; Frosina, D.; Jungbluth, A. A.; Zehir, A.; Benayed, R.; Drilon, A.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Real-world outcomes of an automated physician support system for genome-driven oncology
    Journal Article

    Tao, J. J.; Eubank, M. H.; Schram, A. M.; Cangemi, N.; Pamer, E.; Rosen, E. Y.; Schultz, N.; Chakravarty, D.; Philip, J.; Hechtman, J. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Colorectal carcinomas containing hypermethylated MLH1 promoter and wild-type BRAF/KRAS are enriched for targetable kinase fusions
    Journal Article

    Cocco, E.; Benhamida, J.; Middha, S.; Zehir, A.; Mullaney, K.; Shia, J.; Yaeger, R.; Zhang, L.; Wong, D.; Villafania, L.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma
    Journal Article

    Chiang, S.; Cotzia, P.; Hyman, D. M.; Drilon, A.; Tap, W. D.; Zhang, L.; Hechtman, J. F.; Frosina, D.; Jungbluth, A. A.; Murali, R.; more...
    American Journal of Surgical Pathology (2018)

    Fulltext@MSK | Save
  • Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children
    Journal Article

    Drilon, A.; Laetsch, T. W.; Kummar, S.; DuBois, S. G.; Lassen, U. N.; Demetri, G. D.; Nathenson, M.; Doebele, R. C.; Farago, A. F.; Pappo, A. S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Pan-TRK immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions
    Journal Article

    Hechtman, J. F.; Benayed, R.; Hyman, D. M.; Drilon, A.; Zehir, A.; Frosina, D.; Arcila, M. E.; Dogan, S.; Klimstra, D. S.; Ladanyi, M.; more...
    American Journal of Surgical Pathology (2017)

    Fulltext@MSK | Save